WallStreetZenWallStreetZen

NASDAQ: ACHL
Achilles Therapeutics PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ACHL earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$71.3M
Current Profit Margin
0%

ACHL Return on Equity

Current Company
-34.9%
Current Industry
-17.9%
Current Market
30.8%
ACHL's Return on Equity (-34.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ACHL announces earnings.

ACHL Return on Assets

Current Company
-31.2%
Current Industry
1%
ACHL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ACHL Return on Capital Employed

Current Company
-37.53%
Current Industry
14.2%

ACHL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ACHL$0.00-$67.44M-$71.33MN/AN/A
ICCC$16.01M-$2.79M-$5.32M+10.39%N/A
HEPA$0.00-$51.33M-$51.67MN/AN/A
ELDN$0.00-$88.50M-$88.87MN/AN/A
BYSI$1.35M-$32.87M-$33.28M+173.96%N/A
View Top Biotech Stocks

Achilles Therapeutics Earnings & Revenue FAQ

What were ACHL's earnings last quarter?

On Invalid Date, Achilles Therapeutics (NASDAQ: ACHL) reported Q1 2023 earnings per share (EPS) of -$0.44, up 2.22% year over year. Total Achilles Therapeutics earnings for the quarter were -$17.51 million. In the same quarter last year, Achilles Therapeutics's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Achilles Therapeutics stock.

What was ACHL's earnings growth in the past year?

As of Q2 2023, Achilles Therapeutics's earnings has grown year over year. Achilles Therapeutics's earnings in the past year totalled -$71.33 million.

What was ACHL's revenue last quarter?

On Invalid Date, Achilles Therapeutics (NASDAQ: ACHL) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Achilles Therapeutics's revenue was $0.00.

What was ACHL's revenue growth in the past year?

As of Q2 2023, Achilles Therapeutics's revenue has grown null year over year. Achilles Therapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.